Showing 35,658 results

EACS 2023: ВИЧ-специализированные услуги в Украине не прерываются, но испытывают давление, Пятница, 27 октября 2023

October 2023

EACS 2023: Ucraina, servizi HIV resilienti ma sotto pressione, venerdì 27 ottobre 2023

October 2023
Mpox

Sex is a risk factor for mpox transmission among groups other than gay men

News
27 October 2023
The search for a cure

Three people were gene-edited in an effort to cure their HIV. The result is unknown.

Editor's pick
MIT Technology Review
27 October 2023
Activism & civil society

Former CEO of HIV Scotland to stand trial for embezzlement next year

Editor's pick
Civil Society
27 October 2023

EACS 2023: Serviços para o VIH na Ucrânia resilientes, mas sob pressão, Sexta-feira, 27 de outubro de 2023

October 2023

EACS 2023: Los servicios del VIH en Ucrania se mantienen, pero están sometidos a presión, viernes, 27 de octubre de 2023

October 2023

EACS 2023 : Les services VIH en Ukraine restent solides mais sont sous pression, Vendredi 27 octobre 2023

October 2023
Weight gain & lipodystrophy

GLP-1 receptor agonists promote weight loss among people with HIV One Quarter of PWH Lose More Than 5% of Weight With GLP-1 Agonists

Editor's pick
NATAP
27 October 2023
Hepatitis B

HBcAb positivity is a risk factor for failure to achieve complete virologic suppression of HIV-RNA after antiretroviral switch to 3TC+DTG

Editor's pick
NATAP
27 October 2023
Changing treatment

One Third of French Group Has Not Changed Antiretrovirals for Over 10 Years

Editor's pick
NATAP
27 October 2023

EACS 2023: HIV services in Ukraine resilient but under pressure, Friday 27 October 2023

October 2023
Bone & joint problems

Classic Fracture Risk Factors May Need Replacing in Older People With HIV

Editor's pick
NATAP
27 October 2023
Injectable & long-acting HIV treatment

Long-acting injectable treatment highly effective in European cohort studies

News
26 October 2023
The search for a cure

PD-1 inhibitor budigalimab may delay viral rebound

News
26 October 2023
Injectable & long-acting HIV treatment

Cabotegravir/Rilpivirine Injections Administered During Home Health Visit Show Promise in Pilot Study

Editor's pick
TheBodyPro
26 October 2023
Finding support

Poz Nights at Gay Bars Were Wonderful — And Now Outdated

Editor's pick
HIVPlusMag.com
26 October 2023
Injectable & long-acting HIV treatment

ViiV Healthcare receives approval from China’s national medical products administration for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine)

Editor's pick
ViiV press release
26 October 2023
Access to healthcare

HIV services in Ukraine resilient but starting to feel the strain

News
25 October 2023
Support issues for children & young people

HIV-positive parents in Zimbabwe struggle to manage their children's education – study shows how

Editor's pick
The Conversation
25 October 2023
TB transmission & prevention

Tuberculosis vaccine breakthrough is a significant step forward

Editor's pick
Be In The Know
25 October 2023
Activism & civil society

What’s Lost When an AIDS Walk Becomes a Health Equity Walk?

Editor's pick
POZ
25 October 2023
Discrimination & the law

Tennessee faces federal lawsuit over decades-old penalties targeting HIV-positive people

Editor's pick
NBC News
25 October 2023
PrEP programmes & uptake

Over a million South Africans have used the HIV prevention pill

Editor's pick
Bhekisisa
25 October 2023